Logo image of EXAI.MI

EXPERT.AI SPA (EXAI.MI) Stock Fundamental Analysis

BIT:EXAI - Euronext Milan - IT0004496029 - Common Stock - Currency: EUR

1.36  +0.03 (+2.41%)

Fundamental Rating

3

EXAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 97 industry peers in the Software industry. Both the profitability and financial health of EXAI have multiple concerns. EXAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXAI had negative earnings in the past year.
EXAI had a positive operating cash flow in the past year.
EXAI had negative earnings in each of the past 5 years.
In multiple years EXAI reported negative operating cash flow during the last 5 years.
EXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFEXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

EXAI's Return On Assets of -41.16% is on the low side compared to the rest of the industry. EXAI is outperformed by 83.51% of its industry peers.
With a Return On Equity value of -277.75%, EXAI is not doing good in the industry: 84.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.16%
ROE -277.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXAI.MI Yearly ROA, ROE, ROICEXAI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

EXAI's Gross Margin of 86.10% is amongst the best of the industry. EXAI outperforms 84.54% of its industry peers.
In the last couple of years the Gross Margin of EXAI has grown nicely.
The Profit Margin and Operating Margin are not available for EXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.21%
GM growth 5Y8.75%
EXAI.MI Yearly Profit, Operating, Gross MarginsEXAI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

2

2. Health

2.1 Basic Checks

EXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
EXAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXAI.MI Yearly Shares OutstandingEXAI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
EXAI.MI Yearly Total Debt VS Total AssetsEXAI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

EXAI has an Altman-Z score of 2.23. This is not the best score and indicates that EXAI is in the grey zone with still only limited risk for bankruptcy at the moment.
EXAI has a Altman-Z score of 2.23. This is comparable to the rest of the industry: EXAI outperforms 50.52% of its industry peers.
EXAI has a debt to FCF ratio of 30.16. This is a negative value and a sign of low solvency as EXAI would need 30.16 years to pay back of all of its debts.
EXAI has a Debt to FCF ratio of 30.16. This is comparable to the rest of the industry: EXAI outperforms 42.27% of its industry peers.
EXAI has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.59, EXAI is doing worse than 81.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 30.16
Altman-Z 2.23
ROIC/WACCN/A
WACC8.69%
EXAI.MI Yearly LT Debt VS Equity VS FCFEXAI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

EXAI has a Current Ratio of 0.94. This is a bad value and indicates that EXAI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.94, EXAI is not doing good in the industry: 72.16% of the companies in the same industry are doing better.
A Quick Ratio of 0.94 indicates that EXAI may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, EXAI is not doing good in the industry: 69.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
EXAI.MI Yearly Current Assets VS Current LiabilitesEXAI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.68% over the past year.
Looking at the last year, EXAI shows a very strong growth in Revenue. The Revenue has grown by 39.49%.
EXAI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.05% yearly.
EPS 1Y (TTM)31.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.34%
Revenue 1Y (TTM)39.49%
Revenue growth 3Y-3.77%
Revenue growth 5Y-9.05%
Sales Q2Q%99.19%

3.2 Future

The Earnings Per Share is expected to grow by 53.74% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXAI will show a very strong growth in Revenue. The Revenue will grow by 31.63% on average per year.
EPS Next Y118.18%
EPS Next 2Y53.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year45.79%
Revenue Next 2Y31.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXAI.MI Yearly Revenue VS EstimatesEXAI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
EXAI.MI Yearly EPS VS EstimatesEXAI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXAI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 66.67, EXAI can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as EXAI.
EXAI is valuated expensively when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 66.67
EXAI.MI Price Earnings VS Forward Price EarningsEXAI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

EXAI's Enterprise Value to EBITDA ratio is in line with the industry average.
EXAI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 209
EV/EBITDA 23.55
EXAI.MI Per share dataEXAI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXAI's earnings are expected to grow with 53.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EXAI!.
Industry RankSector Rank
Dividend Yield N/A

EXPERT.AI SPA

BIT:EXAI (5/7/2025, 7:00:00 PM)

1.36

+0.03 (+2.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-28 2025-03-28/amc
Earnings (Next)N/A N/A
Inst Owners3.6%
Inst Owner ChangeN/A
Ins Owners10.04%
Ins Owner ChangeN/A
Market Cap132.38M
Analysts42.22
Price Target1.43 (5.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-6.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-33.33%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.01%
Revenue NY rev (3m)5.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 66.67
P/S 6.44
P/FCF 209
P/OCF 23.11
P/B 16.6
P/tB N/A
EV/EBITDA 23.55
EPS(TTM)-0.24
EYN/A
EPS(NY)0.02
Fwd EY1.5%
FCF(TTM)0.01
FCFY0.48%
OCF(TTM)0.06
OCFY4.33%
SpS0.21
BVpS0.08
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.16%
ROE -277.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.1%
FCFM 3.08%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.21%
GM growth 5Y8.75%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 30.16
Debt/EBITDA 2
Cap/Depr 73.04%
Cap/Sales 24.78%
Interest Coverage N/A
Cash Conversion 90.07%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 2.23
F-Score3
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)100.55%
Cap/Depr(5y)114.56%
Cap/Sales(3y)34.83%
Cap/Sales(5y)34.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.34%
EPS Next Y118.18%
EPS Next 2Y53.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)39.49%
Revenue growth 3Y-3.77%
Revenue growth 5Y-9.05%
Sales Q2Q%99.19%
Revenue Next Year45.79%
Revenue Next 2Y31.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y57.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year264%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.57%
OCF growth 3YN/A
OCF growth 5YN/A